CompletedNot Applicable

Incidence and Predictors of Bleeding During and Following ERCP

Canada5,872 participantsStarted 2018-09-01

Plain-language summary

The incidence of bleeding during ERCP and following ERCP has been estimated using retrospective sources, but granular predictors of bleeding remain unknown, including the use of direct-acting anticoagulants and discontinuation and resumption patterns surrounding their use. In this study, we will aim to assess the incidence and predictors of intra-procedural bleeding during ERCP, and clinically significant post-procedural bleeding following ERCP.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject referred for ERCP, regardless of indication; * Subject age 18 years or older; * Subject able to give informed consent to involvement be included. Exclusion Criteria: * Subject has a standard contraindication to ERCP; * Subject or surrogate unable or unwilling to provide informed consent; * Subject age \< 18 years.

What they're measuring

Clinically significant post-ERCP bleeding

Timeframe: 30 days

Trial details

NCT IDNCT05929404

SponsorUniversity of Calgary

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-30

View on ClinicalTrials.gov More Bleeding UGI (During or Post-ERCP) trials